EDITORIAL
Published on 28 Mar 2024
Editorial: Challenges associated with identifying preclinical animal models for the development of immune-based therapies
doi 10.3389/fimmu.2024.1404085
- 494 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Challenges Associated with Identifying Preclinical Animal Models for the Development of Immune-based Therapies
Challenges Associated with Identifying Preclinical Animal Models for the Development of Immune-based Therapies
25k
Total Downloads
87k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 04 Jan 2024
Peptoniphilus gorbachii alleviates collagen-induced arthritis in mice by improving intestinal homeostasis and immune regulation
doi 10.3389/fimmu.2023.1286387
- 1,284 views
REVIEW
Published on 19 Dec 2023
Single cell RNA-sequencing profiling to improve the translation between human IBD and in vivo models
doi 10.3389/fimmu.2023.1291990
- 4,537 views
- 1 citation
REVIEW
Published on 28 Nov 2023
DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies
doi 10.3389/fimmu.2023.1264882
- 2,316 views
ORIGINAL RESEARCH
Published on 18 Oct 2023
Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and impact response to immuno-oncology treatments
doi 10.3389/fimmu.2023.1258291
- 1,623 views
- 3 citations
ORIGINAL RESEARCH
Published on 15 Sep 2023
Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against Staphylococcus aureus-induced acute circulatory failure in a mechanically ventilated rabbit model of hyperdynamic septic shock
doi 10.3389/fimmu.2023.1260627
- 1,677 views
- 3 citations
REVIEW
Published on 07 Sep 2023
Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy
doi 10.3389/fimmu.2023.1236965
- 1,962 views
- 3 citations
ORIGINAL RESEARCH
Published on 21 Jul 2023
Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 mice
doi 10.3389/fimmu.2023.1187388
- 2,642 views
- 1 citation
ORIGINAL RESEARCH
Published on 10 Jul 2023
Construction of the systemic anticancer immune environment in tumour-bearing humanized mouse by using liposome-encapsulated anti-programmed death ligand 1 antibody-conjugated progesterone
doi 10.3389/fimmu.2023.1173728
- 2,191 views
- 4 citations
REVIEW
Published on 09 May 2023
Preclinical models and evaluation criteria of prostatitis
doi 10.3389/fimmu.2023.1183895
- 6,097 views
- 7 citations
ORIGINAL RESEARCH
Published on 21 Apr 2023
Late-stage MC38 tumours recapitulate features of human colorectal cancer – implications for appropriate timepoint selection in preclinical studies
doi 10.3389/fimmu.2023.1152035
- 9,519 views
- 3 citations
ORIGINAL RESEARCH
Published on 14 Apr 2023
Unique structure of ozoralizumab, a trivalent anti-TNFα NANOBODY® compound, offers the potential advantage of mitigating the risk of immune complex-induced inflammation
doi 10.3389/fimmu.2023.1149874
- 4,546 views
- 9 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Alloimmunity and Transplantation
- Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
- Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- NK and Innate Lymphoid Cell Biology
- Mucosal Immunity
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 87kTopic views
- 58kArticle views
- 25kArticle downloads